Daxor CEO Michael Feldschuh to Engage Investors at Exclusive Maxim Growth Summit Oct 21, 2025 08:00AM
Daxor Corporation Announces Partial Exercise of Over-Allotment Option in Secondary Offering Jun 22, 2023 04:15PM
Daxor Corporation to Participate in the Maxim Group Virtual Healthcare Conference Jun 12, 2023 08:00AM
Daxor Corporation Announces Closing of $4.0 Million Underwritten Public Offering May 25, 2023 03:37PM
Daxor Corp. (DXR) Prices 410K Share Offering at $9.75/sh May 22, 2023 08:30AM


May 22, 2023 08:30AM Daxor Corporation Announces Pricing of $4.0 Million Underwritten Public Offering
May 19, 2023 04:53PM Daxor Corp. (DXR) Announces Proposed Stock Offering, Size not Disclosed
May 19, 2023 04:53PM Daxor Corporation Announces Proposed Underwritten Public Offering
Mar 23, 2022 08:00AM Daxor Corporation to Participate in the Maxim Group 2022 Virtual Growth Conference
Mar 23, 2022 08:00AM Daxor Corporation to Participate in the Maxim Group 2022 Virtual Growth Conference
Mar 16, 2021 08:30AM Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference
Mar 16, 2021 08:30AM Daxor to Participate in the Maxim Group 2021 Emerging Growth Virtual Conference
May 26, 2020 04:50PM Daxor Corporation, CEO Michael Feldschuh to Participate in Maxim Group’s COVID-19 Virtual Conference on May 27, 2020
May 26, 2020 04:50PM Daxor Corporation, CEO Michael Feldschuh to Participate in Maxim Group’s COVID-19 Virtual Conference on May 27, 2020
Mar 6, 2020 08:04AM Daxor Corp. (DXR) Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market
Mar 6, 2020 08:00AM Daxor Corporation Announces Closing of $2.0 Million Registered Direct Offering Priced At-The-Market
Jul 29, 2019 07:40AM Maxim Group Starts Daxor Corp. (DXr) at Buy